OverviewChartNewsTraderScreen

Supernus Pharmaceuticals/  US8684591089  /

IEX
2024-04-25  9:59:54 PM Chg. -0.98 Volume Bid- Ask- High Low
29.28USD -3.24% 10,643
Turnover: 314,367.63		 -Bid Size: - -Ask Size: - 30.14 29.16
GlobeNewswire 04-24 Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call o...
GlobeNewswire 04-24 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmac...
GlobeNewswire 04-08 Supernus Provides Regulatory Update for SPN-830
GlobeNewswire 03-26 MannKind Announces CFO Transition
GlobeNewswire 03-06 Supernus to Participate in Two Upcoming Investor Conferences
GlobeNewswire 02-28 Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
GlobeNewswire 02-27 Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-13 Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Co...
GlobeNewswire 02-05 Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
GlobeNewswire 02-02 SAB Biotherapeutics Announces Executive Leadership Change
GlobeNewswire 2023-11-08 Supernus Announces Third Quarter 2023 Financial Results
GlobeNewswire 2023-11-07 Supernus to Participate in the Jefferies London Healthcare Conference
GlobeNewswire 2023-11-02 Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
GlobeNewswire 2023-10-25 Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call o...
GlobeNewswire 2023-10-16 Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journe...
GlobeNewswire 2023-10-10 Zevra Therapeutics Appoints Neil F. McFarlane as President, Chief Executive Officer and Director
GlobeNewswire 2023-10-09 Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
GlobeNewswire 2023-09-27 Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York Cit...
GlobeNewswire 2023-09-10 Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms
GlobeNewswire 2023-08-31 Supernus to Participate in the Wells Fargo Healthcare Conference
GlobeNewswire 2023-08-21 Bethany L. Sensenig Joins Supernus’ Board of Directors
GlobeNewswire 2022-03-17 Supernus Notifies Nasdaq Regarding Non-Compliance with Listing Requirement and Expectation to Regain...
GlobeNewswire 2022-03-07 Freshworks Enables Supernus Pharmaceuticals to Scale Operational Excellence and Get Critical Medicat...
GlobeNewswire 2022-03-02 Supernus to Participate in Annual Cowen Health Care Conference
GlobeNewswire 2022-02-28 Supernus Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results